Necitumumab Intravenous and Sinemet 250/25
Determining the interaction of Necitumumab Intravenous and Sinemet 250/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Necitumumab Intravenous-Sinemet CR
- Necitumumab Intravenous-Sinemet CR 100/25
- Necitumumab Intravenous-Sinemet CR 200/50
- Necitumumab Intravenous-Sinequan
- Necitumumab Intravenous-Sinequan (Doxepin Capsules)
- Necitumumab Intravenous-Sinequan (Doxepin Oral Concentrate)
- Sinemet 250/25-Necon
- Sinemet 250/25-Necon 0.5/35
- Sinemet 250/25-Necon 1/35
- Sinemet 250/25-Necon 1/50
- Sinemet 250/25-Necon 1/50 (28)
- Sinemet 250/25-Necon 7/7/7